Bloomberg -- Novartis AG’s Onbrez Breezhaler was more effective than a standard medicine used in a GlaxoSmithKline Plc product in a late-stage study of patients with smoker’s cough.
Bloomberg -- Novartis AG’s Onbrez Breezhaler was more effective than a standard medicine used in a GlaxoSmithKline Plc product in a late-stage study of patients with smoker’s cough.